Tech Company Financing Transactions
Curebase Funding Round
On 5/5/2022, Curebase raised $40 million in Series B investment from Industry Ventures, aCrew Capital and Bold Capital Partners.
Transaction Overview
Company Name
Announced On
5/5/2022
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
Industry Ventures (Lead Investor) (Fanni Fan)
GGV Capital (Jeffrey Richards)
Proceeds Purpose
This funding will deepen Curebase's breadth of capabilities beyond the virtual experience: via more complex site and community healthcare interfaces, a richer range of clinical software and services, and more robust capabilities for interventional drug sponsors and global studies.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
335 S Van Ness Ave.
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Website
Email Address
Overview
Curebase's software technology and virtual staff enables recruitment and clinical data collection settings almost anywhere - from local clinics, to mobile care, telehealth, drive through sites, pharmacies and more. The most flexible decentralized clinical research solution.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Lemberg
Browse more venture capital transactions:
Prev: 5/5/2022: Logseq venture capital transaction
Next: 5/5/2022: Alan venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs